AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Marpai, Inc.
Video analysis: MRAI
All videosNo video analysis for this stock yet. Request one from our team.
News: MRAI
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #ClaimsManagement--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that Marpai, Inc. (OTCQX: MRAI) has expanded its relationship with Claritev to bring comprehensive pre- and post-payment integrity capabilities to the health plans and claims it administers. Marpai currently uses Claritev's PHCS® Network to provide access to healthcare providers and negotiated rates outside its clients' primary networks. The expanded agreement ex.
Marpai Reports Second Quarter 2026 Financial Results
Successful turnaround leads to lower operating costs and improved gross margin; debt restructuring and subsequent financing strengthen capital structure TAMPA, Fla., Aug. 13, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management ("PBM") services, announced its financial and operational results for the three and six months ended June 30, 2026.
Marpai Announces $12 Million Private Placement led by Mitchell Companies
TAMPA, Fla., July 29, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit Management ("PBM") services, today announced that it entered into securities purchase agreements with accredited investors in a private placement of newly designated convertible preferred stock.
Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity
Debt restructuring aligns capital structure, with projected operational cash flows, and unlocks capital for growth TAMPA, Fla., July 20, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit Management ("PBM") services, today announced that it has entered into debt restructuring agreements with JGB Capital, in May 2026, and AXA S.A.
